High-dose beclometasone dipropionate/formoterol fumarate in fixed-dose combination for the treatment of asthma

The high-strength formulation of extrafine beclometasone dipropionate/formoterol fumarate (BDP/Form) 200/6 µg has been developed to step up inhaled corticosteroid treatment, without increasing the dose of the bronchodilator, in patients who are not controlled with previous therapies. Two clinical st...

Descripción completa

Detalles Bibliográficos
Autores principales: Corradi, Massimo, Spinola, Monica, Petruzzelli, Stefano, Kuna, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933614/
https://www.ncbi.nlm.nih.gov/pubmed/27340255
http://dx.doi.org/10.1177/1753465816654442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933614/
https://www.ncbi.nlm.nih.gov/pubmed/27340255
http://dx.doi.org/10.1177/1753465816654442

Ejemplares similares